Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Illinois at Chicago

About this trial

Approximately 50% of people with multiple sclerosis (MS) use a wheelchair within 30 years of the initial diagnosis. Wheelchair use in MS is often associated with fatigue as a consequence of muscle weakness. Indeed, fatigue, a prevalent consequence of MS, often becomes debilitating and exhausts energetic resources when carrying-out tasks of daily life and/or interacting with the community, as these require ambulatory mobility. This experience of excessive fatigue has its roots in muscle weakness and results in reliance on a wheelchair for mobility, and the dependency on a wheelchair may further reduce muscular strength, particularly of the lower extremities. We propose that wheelchair users with MS can increase muscular strength through a personalized exercise rehabilitation, and this in turn will improve ambulatory performance and possibly reduce fatigue. To date, no research has examined the effects of this specific exercise rehabilitation program (GH method) on physical function and other disease-related outcomes in persons with MS who use wheelchairs as a primary mobility device.

Eligibility criteria

Qualifiers

diagnosis of MS

age above 18 years

no relapse within last 30 days

use of wheelchair for mobility in the community

Disqualifiers

no diagnosis of MS

less than 18 years of age

not relapse-free within the last 30 days

no use of wheelchair as primary mobility device

Trial design

Treatments tested in this trial

  • Exercise rehabilitation program

Treatment groups

24 Participants
are divided into 2 treatment groups